32
Participants
Start Date
February 6, 2023
Primary Completion Date
August 15, 2023
Study Completion Date
December 31, 2023
Anti-Hypertensive
Based on information entered by the CHWs into the CommCare application designed for this study, the application will provide recommendations (and underlying rationale for these recommendations) for prescription of antihypertensives (amlodipine and/or losartan OR enalapril) and medications to reduce cardiovascular risk (aspirin and atorvastatin) if indicated, lifestyle modification, and referral to the supervising physician if indicated for potential complications of hypertension.
San Lucas Mission, San Lucas Tolimán
Fogarty International Center of the National Institute of Health
NIH
University of Wisconsin, Madison
OTHER